[1] |
ZHENG Jiantao, YANG Yong, ZHOU Dong.
Clinical significance of CX43 expression and immune cell infiltration in glioma: based on TCGA data analyses
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 250-254,261.
|
[2] |
WAN Xin, HU Yue, ZHANG Ju, CHEN Yun, JIN Peipei.
Human herpesvirus 6A subtype affects the expression of LncRNA MEG3,proliferation,apoptosis and EMT process in glioma cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 352-358.
|
[3] |
DONG Qiang, XIE Qiqi, HU Jianhong, WANG Maolin, YUAN Guoqiang, PAN Yawen.
Bioinformatic analysis of expression and clinical significance of formyl peptide receptor 1 in gliomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 457-462.
|
[4] |
GAO Fei, WANG Yingbin.
Experimental transcarotid artery chemotherapy on gliomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(1): 62-66.
|
[5] |
PAN Qi, LI Meng, QIAN Fengcui, TANG Zhidong, ZHAO Yue, WANG Qiuyu, LI Chunquan.
Copy number of gene and their expression as survival markers for glioma
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(1): 23-30,36.
|
[6] |
HE Jie, WAN Jinghai, LI Xueji, QIAN Haipeng, MENG Xiaoli, HAO Jiajie, XU Xin, WANG Mingrong.
TERT promoter mutation is a potential biomarker for predicting poor outcome in gliomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2015, 27(5): 361-365.
|
[7] |
GAO Fei, YOU Tian, LU Jing-yu, WANG Yun-jie.
The Expression of CAGE Gene and Its Mechanism in Intracranial Tumors
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2007, 19(3): 239-242.
|
[8] |
JIANG You-hong, SUI Cheng-guang, MENG Fan-dong, MA Ping, WANG Xiao-hua, DAI Xiao-chun.
Correlation Analysis Between Expression of P21WAF1/CIP1,P16 Proteins and Human Gliomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2005, 17(5): 311-313.
|
[9] |
MU Yong-gao, CHEN Zhong-ping, ZHANG Xiang-heng, et al.
Preliminary Results of Immunotherapy Against Malignant Gliomas Using Autologous Tumor Cell Vaccine
[J]. , 2004, 16(4): 208-210.
|